Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date September 15, 2023
Nasdaq Short Interest Days Nasdaq Short Interest Days NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- At the end of...
Read moreDetails
Senti Bio to Participate in Upcoming Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company...
Read moreDetailsThe Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit
CERRITOS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (TOI) is excited to announce...
Read moreDetailsPromaxo to Showcase In-Office MRI System and Compatible Robot System in Upcoming Trade Conferences
Promaxo Exhibit Booth ASTRO 2023 Promaxo is planning to showcase its minimally-invasive and patient-centric MRI and robotic platform at Booth...
Read moreDetailsFarmers & Merchants Bancorp, Inc. Declares 2023 Third-Quarter Cash Dividend
ARCHBOLD, Ohio, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of Farmers & Merchants Bancorp, Inc., (Nasdaq: FMAO)...
Read moreDetailsAvid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
TUSTIN, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO)...
Read moreDetailsAAR reports first quarter fiscal year 2024 results
First quarter sales of $550 million, up 23% over the prior yearParts Supply sales up 40% over the prior yearFirst...
Read moreDetailsNasdaq to Hold Third Quarter 2023 Investor Conference Call
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Third Quarter 2023 financial results announcement....
Read moreDetailsNextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease
Data presented at the 2023 Cambridge Health Tech Institute's 2nd Annual Neurodegeneration Targets Conference in Boston, MAIn preclinical testing, NC181...
Read moreDetailsAdverum Biotechnologies Announces Positive Aflibercept Protein Level Data from the LUNA Phase 2 Trial
Aqueous Aflibercept Protein Expression Levels in LUNA and OPTIC Trials Aqueous aflibercept protein expression levels from LUNA and OPTIC trials...
Read moreDetailsADVERTISEMENTS
